PBC treatment Livdelzi shows benefits for 2.5 years in Phase 3 trial
After 2.5 years of Livdelzi (seladelpar) treatment, more than 4 in 5 adults…
Cholangitis
Featured resources
Cholangitis overview: What you should know
Cholangitis is a liver condition characterized by inflammation in the bile ducts, most commonly caused by a bacterial infection but also may develop due to a variety of other causes.
Read more
Cholangitis treatment and management options
A variety of treatments may be used to treat cholangitis, depending on the type and whether it is acute or chronic.
Read moreLatest news
FDA rejects full approval of Ocaliva as second-line PBC treatment
The U.S. Food and Drug Administration (FDA) has turned down a request by…
